|Day Low/High||37.87 / 38.40|
|52 Wk Low/High||31.56 / 43.84|
NEW YORK, April 25, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:BSX) of the June 24, 2019 deadline to seek the role of...
SAN DIEGO, April 25, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP reminds investors that a class action lawsuit has been filed against Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific") on behalf of all purchasers of...
MARLBOROUGH, Mass., April 24, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $2.
Transcatheter Aortic Valve Replacement Technology for Patients with Severe Aortic Stenosis Designed to Minimize Paravalvular Leakage, Offer Controlled Delivery and Repositionability Post Deployment
NEW YORK, April 23, 2019 /PRNewswire/ -- Advanced Disposal Services, Inc. (ADSW) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with the proposed sale of ADSW to Waste Management, Inc.
NEW YORK, April 19, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE: BSX).
Shares jump nearly 8% following agreement to pay rival Boston Scientific Corp. 4180 million to settle long-standing patent disputes.
Healthcare has been the best performing sector of the market this year. Here are three buy-rated stocks to track now.
Jim Cramer says most - but not all - stocks are in a bear market. He talks about what's happening with Clorox, Coca-Cola, Verizon, Apple and more.
Jim Cramer takes a look at Analog Devices, MongoDB, Welltower, Ventas, Iridium Communications, Huntington Bancshares, Citigroup, Randgold Resources and more.
Boston Scientific offered $10.77 for each BTG share, valuing the company at $4.2 billion.
FAANG stocks are sliding into bear market territory, retail earnings dominate today's corporate calendar, housing starts and building permits will test US rate hike bets, Boston Scientific makes $4.2 billion U.K. play and Carlos Ghosn could be left by the roadside - Five Things You Must Know Before the Bell.
Straying from these names could land you in quicksand as the 4th quarter begins.
For most of this year the market has been led by growth stocks.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
The Healthcare sector has seen a revitalization year-to-date, and these investors may have wanted to participate in a continued move higher, risking a fraction of the price of a share in the event they were 'late to the party.'
Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.
It is all about perception, and here are strong names to pick up on market weakness.
The heart-implant manufacturer is down some 4% over two days, but is up 128% year to date.
Jim Cramer takes a closer look at Magellan Midstream Partners, Xylem, Boston Scientific, Karyopharm Thereapeutics, Iovance Biotherapeutics, Casella Waste Systems and more.
Jim Cramer says higher rates always trigger rotations. Here's what investors should expect.
Jim Cramer and our other experts discuss the AT&T/Time Warner ruling, Alzheimer plays, and day traders risk.
The medical device firm issues an 8-K filing on the heels of a media report earlier this week that said it recently made a takeover approach to Boston Scientific.
Stocks closed higher on Monday as Wall Street prepares for an extraordinary week for risk events around the world.
Jim Cramer and our other experts discuss Trump and stocks, trade, and pajama trading.
The Wall Street Journal reports Stryker made a takeover approach for the medical device company.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMCX, APAM, BEAT, BSX, CIO, CRZO, EFII, FNB, LNDC, NTWK, OXSQ, SIR, VOC, WHG Downgrades: ABEV, ARNC, BMS, EMCI, ERII, ESGR, ESLT, GASS, IVZ, LPL, PICO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.